Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.
University of Utah School of Medicine, Salt Lake City, UT, USA. Guido.Tricot@ hsc.utah.edu
Guido
G
Tricot
Maurizio
M
Zangari
Roberto
R
Sorasio
Benedetto
B
Bruno
D000368:Aged; D018450:Disease Progression; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008024:Ligands; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology* / Q000628:therapy*; D010950:Plasma Cells / Q000276:immunology*; D011379:Prognosis; D051437:Renal Insufficiency / Q000150:complications; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D008024:Ligands